Novel Therapeutic Target for Depression Identified
An anti-seizure medication appears to reduce anhedonia in patients with depression via a novel mechanism that may offer a new therapeutic target for the disorder, new research suggests. Results of a small, randomized trial show those who received ezogabine (Potiga) experienced a significant reduction in key measures of depression and anhedonia vs placebo. Participants in […]
Novel Therapeutic Target for Depression Identified Read More »